12/05/2024 8:34 PM | AXIM Biotechnologies (Filer)
| Form 15-12G | |
11/13/2024 2:31 PM | AXIM Biotechnologies (Filer)
| Form NT 10-Q | |
10/15/2024 3:44 PM | AXIM Biotechnologies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 4:05 PM | AXIM Biotechnologies (Issuer) Valencia Catalina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:14 PM | AXIM Biotechnologies (Filer)
| Form NT 10-Q | |
05/20/2024 3:24 PM | AXIM Biotechnologies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024 4:25 PM | AXIM Biotechnologies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/01/2024 1:55 PM | AXIM Biotechnologies (Filer)
| Form NT 10-K | |
03/21/2024 2:47 PM | AXIM Biotechnologies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 6:59 PM | AXIM Biotechnologies (Issuer) HUEMOELLER JOHN WALTER II (Reporting)
| Form 4/A | |
03/19/2024 6:29 PM | AXIM Biotechnologies (Issuer) Scott Timothy Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:33 PM | AXIM Biotechnologies (Issuer) Cunningham Robert L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:37 PM | AXIM Biotechnologies (Issuer) Schroeder Blake (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:39 PM | AXIM Biotechnologies (Issuer) Valencia Catalina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:14 PM | AXIM Biotechnologies (Issuer) HUEMOELLER JOHN WALTER II (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:16 PM | AXIM Biotechnologies (Issuer) MALASEK ROBERT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 6:24 PM | AXIM Biotechnologies (Issuer) O'Rourke Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 10:59 AM | AXIM Biotechnologies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |